Skip to main content
TipRanks
Go Ultimate75% OFF

Meghmani Organics Limited (MOL) AI Stock Analysis

3 Followers
IN:MOL

Meghmani Organics Limited

(NSE:MOL)

Select Model
Rating:57Neutral
Price Target:INR 56.00â–²(3.51% Upside)
Action:reiterated
Date:08/25/26

The overall score is constrained by weak financial performance and an expensive valuation. The company's thin profitability and high P/E ratio are significant risks. However, strong bullish technical momentum and a stable balance sheet provide some support, lifting the score from the lower end of the range.

Positive Factors
Earnings and Cash Flow RecoveryThe return to positive earnings and free cash flow in 2026 marks a meaningful improvement from the prior period. If maintained, this recovery can strengthen internal funding capacity, support operations, and provide a firmer base for rebuilding profitability over the next several quarters.
Negative Factors
Thin and Volatile ProfitabilityAlthough earnings recovered in 2026, very thin operating and net margins leave limited room to absorb weaker pricing, demand changes, or higher costs. The recent losses and volatility also reduce confidence that the improved earnings level will be consistently sustained.

Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)

-50%-40%-30%-20%-10%0%10%IN:MOL-22.36%INDA-5.34%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 13.84B
Dividend Yield
―
Average Volume (3M)
84.20K
Price to Earnings (P/E)
15.9
Beta (1Y)
1.35
Revenue Growth
-5.19%
EPS Growth
118.24%
Country
India
Employees
1,154
Sector
General
Sector Strength
55
Industry
Agricultural Inputs

Meghmani Organics Limited Business Overview & Revenue Model

Company Description

Meghmani Organics Limited, founded in 1986 and headquartered in Ahmedabad, India, operates as a producer and supplier of an extensive range of pigments and agrochemical products, catering to markets both within India and globally. The company's pigme...

Meghmani Organics Limited Financial Statement Overview

Summary

Financial performance is mixed. The company returned to profitability and generated positive free cash flow, but revenue is volatile and margins remain thin. The balance sheet is stable with moderate leverage, though return on equity is low. Overall, recent recovery is encouraging but sustainability is unproven.

Income Statement

45Neutral

Balance Sheet

60Neutral

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue21.93B21.74B21.24B15.48B25.28B24.73B
Gross Profit6.82B5.93B8.60B4.44B9.30B9.41B
EBITDA2.93B2.73B1.87B119.50M4.10B4.81B
Net Income865.79M287.39M-106.01M-1.06B2.38B3.04B
Balance Sheet
Total Assets31.94B30.21B30.85B30.40B31.98B27.98B
Cash, Cash Equivalents and Short-Term Investments175.56M264.88M227.24M330.74M1.52B117.22M
Total Debt6.64B7.26B8.29B8.37B8.24B4.99B
Total Liabilities15.66B14.76B15.70B15.12B15.29B13.31B
Stockholders Equity16.27B15.45B15.15B15.28B16.69B14.66B
Cash Flow
Free Cash Flow0975.10M-226.88M-165.29M-2.61B-1.79B
Operating Cash Flow01.43B662.22M2.50B2.04B648.32M
Investing Cash Flow0-458.42M309.70M-1.78B-4.18B-1.33B
Financing Cash Flow0-1.04B-913.88M-854.77M2.34B577.19M

Meghmani Organics Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price54.10

Price Trends

50DMA58.18Negative
100DMA56.24Negative
200DMA53.37Positive

Market Momentum

MACD-0.77Negative
RSI44.24Neutral
STOCH35.03Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Negative. The current price of 54.10 is below the 20-day moving average (MA) of 54.78, below the 50-day MA of 58.18, and above the 200-day MA of 53.37, indicating a neutral trend. The MACD of -0.77 indicates Negative momentum. The RSI at 44.24 is Neutral, neither overbought nor oversold. The STOCH value of 35.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MOL.

Meghmani Organics Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:MOL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:DHANUKAIN:DHANUKA73OutperformINR 39.92B14.30―0.22%-0.06%0.75%
IN:SHARDACROPIN:SHARDACROP73OutperformINR 65.13B10.09―2.08%17.28%42.45%
IN:PIINDIN:PIIND58NeutralINR 254.89B29.02―0.59%-14.95%-41.96%
IN:UPLIN:UPL57NeutralINR 472.73B25.19―1.07%10.33%-14.32%
IN:MOLIN:MOL57NeutralINR 13.74B15.87――-5.19%118.24%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:IPLIN:IPL51NeutralINR 13.55B14.29―0.64%2.89%-9.47%

* General Sector Average

Performance Comparison

-50%-25%0%25%50%IN:MOLIN:DHANUKAIN:IPLIN:PIINDIN:SHARDACROPIN:UPLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:MOL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:MOLMeghmani Organics Limited54.10-15.55-22.33%
IN:DHANUKADhanuka Agritech Limited931.90-274.02-22.72%
IN:IPLIndia Pesticides Ltd.116.80-59.95-33.92%
IN:PIINDPI Industries Limited1670.60-1750.97-51.17%
IN:SHARDACROPSharda Cropchem Ltd.709.55-44.56-5.91%
IN:UPLUPL Limited554.00-191.29-25.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 25, 2026